TITLE

Novo Nordisk quits small molecules

AUTHOR(S)
Chynoweth, Emma
PUB. DATE
January 2007
SOURCE
ICIS Chemical Business;1/22/2007, Vol. 2 Issue 50, p30
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the move made by Novo Nordisk AS to refocus its research and development efforts in order to concentrate on its growing pipeline of protein-based pharmaceuticals. Some of the firm's pipeline of products are given including treatment for diabetes, haemostasis and growth disorders. Information on the core competencies of the company is also presented.
ACCESSION #
23977596

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics